ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 634785 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 634785; 2) Community: the network communities that were significantly associated with the response to NSC 634785; 3) Molecule: the relationships between components within communities and NSC 634785; 4) MDR: the compounds that were significantly associated with the NSC 634785.

NSC Compound Enrichment Correlation
NSC 679024 1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- 0.0480633950058475 0.29145523
NSC 679516 Null 0.0480633950058475 0.40497016
NSC 685285 Null 0.0480633950058475 0.15902758
NSC 711077 Null 0.0480633950058475 0.20122794
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.37074936
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.30384602
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0480633950058475 0.15046155
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 0.46258518
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0480633950058475 0.29648505
NSC 749600 Null 0.0480633950058475 0.50080343
Total:114  Current:112    [First] [Prev] [Next] [Last]